Evidence map›Paper›PMID 42015143›Full record

ReviewCell communication and signaling : CCS2026

The roles of IKKα in normal physiology and cancer.

Simoni Besta, Mark Samuels, Eugenia Roupakia, Dimitris C Kanellis, Kenneth B Marcu, Evangelos Kolettas

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simoni BestaLaboratory of Biology, School of Medicine, Faculty of Health Sciences, and Institute of Biosciences, Centre for Research and Innovation, University of Ioannina, Ioannina, Greece. simonibesta@gmail.com.
Mark SamuelsDepartment of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, BN1 9QG, UK.
Eugenia RoupakiaLaboratory of Biology, School of Medicine, Faculty of Health Sciences, and Institute of Biosciences, Centre for Research and Innovation, University of Ioannina, Ioannina, Greece.
Dimitris C KanellisScience for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, S-171 21, Sweden.
Kenneth B MarcuDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, 11794-5215, USA.
Evangelos KolettasLaboratory of Biology, School of Medicine, Faculty of Health Sciences, and Institute of Biosciences, Centre for Research and Innovation, University of Ioannina, Ioannina, Greece. ekoletas@uoi.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IkappaB kinase alpha (IKKα) is a multifunctional serine/threonine kinase and a core component of the IKK complex, best known for its central role in canonical and non-canonical nuclear factor kappaB (NF-κB) signalling. While early studies primarily focused on these roles in NF-κB signalling, emerging evidence highlights a much broader spectrum of functions, extending far beyond these classical roles. IKKα is now known to govern diverse biological processes, including cell cycle regulation, epidermal differentiation, tissue homeostasis and development through NF-κB-independent mechanisms, acting as a transcriptional and epigenetic regulator and signalling mediator. In cancer, IKKα has dual, context-specific activities, both as a tumour suppressor through inhibition of cell growth in some settings, while also working as a potent oncogene driving cell proliferation, metastasis and therapy resistance in other settings. This review synthesises the current knowledge of IKKα in both physiological and pathological contexts, highlighting its multifaceted roles in cancer development and discussing emerging therapies targeting IKKα for cancer treatment.

Indexed as

I-kappa B KinaseNeoplasmsAnimalsHumansNF-kappa BSignal TransductionI-kappa B KinaseNF-kappa BCancerCHUKIKKαNF-κBSer/Thr kinases

Identifiers

PMID42015143
PMCPMC13227634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.